[ACS] Asymmetric Synthesis of MK-7845, an Investigational Treatment for COVID-19

iffee82 Post time 7 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-09-11 13:41
Reward10points

journal:Organic Letters

Authors:Reed T. Larson; Ben W. H. Turnbull; Patrick J. Moon; Dan Lehnherr; Jonathan M. E. Hughes; Stasik Popov; Gilmar A. Brito; Teresa Andreani; Suhong Kim; James Herbort; Renee J. Sifri; Shorouk O. Badir; Chibueze I. Onyeagusi; Nicholas R. Deprez; Douglas Otte; Donald R. Gauthier; Nadine Kuhl; Yining Ji; Andrew J. Neel; Ryan D. Cohen; Jeffrey S. Derrick; Cecilia Bottecchia; Clara Hartmanshenn; David A. Vargas; Guilherme Dal Poggetto; Alex M. Confer; Michelle Zheng; Yangzhong Qin; Ajit Vikram; Justin A. Newman; Zeinab Sakhaei; Riki J. Drout; Lu Chen; Zheng Wu; Steve Castro; Stella K. Betancourt; Gurpreet Longia; Brittany Kassim; Yingju Xu; Jamie M. McCabe Dunn; Nastaran Salehi Marzijarani

Published date:2025-11-14

DOI:10.1021/acs.orglett.5c03920

PDF link:https://pubs.acs.org/doi/pdf/10.1021/acs.orglett.5c03920

Article link:https://doi.org/10.1021/acs.orglett.5c03920

Article Source:American Chemical Society (ACS)


Remark:

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
17c@r@t Post time 7 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    190

Return to the list